Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95

1.

A portable magneto-optical trap with prospects for atom interferometry in civil engineering.

Hinton A, Perea-Ortiz M, Winch J, Briggs J, Freer S, Moustoukas D, Powell-Gill S, Squire C, Lamb A, Rammeloo C, Stray B, Voulazeris G, Zhu L, Kaushik A, Lien YH, Niggebaum A, Rodgers A, Stabrawa A, Boddice D, Plant SR, Tuckwell GW, Bongs K, Metje N, Holynski M.

Philos Trans A Math Phys Eng Sci. 2017 Aug 6;375(2099). pii: 20160238. doi: 10.1098/rsta.2016.0238.

2.

A Rab20-Dependent Membrane Trafficking Pathway Controls M. tuberculosis Replication by Regulating Phagosome Spaciousness and Integrity.

Schnettger L, Rodgers A, Repnik U, Lai RP, Pei G, Verdoes M, Wilkinson RJ, Young DB, Gutierrez MG.

Cell Host Microbe. 2017 May 10;21(5):619-628.e5. doi: 10.1016/j.chom.2017.04.004.

3.

Cmr is a redox-responsive regulator of DosR that contributes to M. tuberculosis virulence.

Smith LJ, Bochkareva A, Rolfe MD, Hunt DM, Kahramanoglou C, Braun Y, Rodgers A, Blockley A, Coade S, Lougheed KEA, Hafneh NA, Glenn SM, Crack JC, Le Brun NE, Saldanha JW, Makarov V, Nobeli I, Arnvig K, Mukamolova GV, Buxton RS, Green J.

Nucleic Acids Res. 2017 Jun 20;45(11):6600-6612. doi: 10.1093/nar/gkx406.

4.

Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.

Squires K, Bekker LG, Katlama C, Yazdanpanah Y, Zhou Y, Rodgers AJ, DiNubile MJ, Sklar PA, Leavitt RY, Teppler H.

Open Forum Infect Dis. 2017 Feb 28;4(1):ofw047. doi: 10.1093/ofid/ofw047. eCollection 2017 Winter.

5.

National drug policy reform for noncommunicable diseases in low-resource countries: an example from Bangladesh.

Islam SMS, Islam MT, Islam A, Rodgers A, Chow CK, Naheed A.

Bull World Health Organ. 2017 May 1;95(5):382-384. doi: 10.2471/BLT.15.161117. Epub 2016 Apr 5. No abstract available.

6.

Electrochemical Investigation of Adsorption of Single-Wall Carbon Nanotubes at a Liquid/Liquid Interface.

Rabiu AK, Toth PS, Rodgers AN, Dryfe RA.

ChemistryOpen. 2016 Dec 13;6(1):57-63. doi: 10.1002/open.201600136. eCollection 2017 Feb.

7.

Evaluating factors influencing the delivery and outcomes of an incentive-based behaviour change strategy targeting child obesity: protocol for a qualitative process and impact evaluation.

Enright G, Gyani A, Raadsma S, Allman-Farinelli M, Rissel C, Innes-Hughes C, Lukeis S, Rodgers A, Redfern J.

BMJ Open. 2016 Dec 16;6(12):e012536. doi: 10.1136/bmjopen-2016-012536.

8.

Design Considerations in Development of a Mobile Health Intervention Program: The TEXT ME and TEXTMEDS Experience.

Thakkar J, Barry T, Thiagalingam A, Redfern J, McEwan AL, Rodgers A, Chow CK.

JMIR Mhealth Uhealth. 2016 Nov 15;4(4):e127.

9.

Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases.

Chow CK, Islam SM, Farmer A, Bobrow K, Maddision R, Whittaker R, Dale LP, Lechner A, Niessen L, Lear SA, Eapen ZJ, Santo K, Stepien S, Redfern J, Rodgers A.

BMJ Open. 2016 Oct 17;6(10):e012723. doi: 10.1136/bmjopen-2016-012723.

10.

An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial.

Hayek A, Joshi R, Usherwood T, Webster R, Kaur B, Saini B, Armour C, Krass I, Laba TL, Reid C, Shiel L, Hespe C, Hersch F, Jan S, Lo S, Peiris D, Rodgers A, Patel A.

Implement Sci. 2016 Sep 23;11(1):129.

11.

The proneurotrophin receptor sortilin is required for Mycobacterium tuberculosis control by macrophages.

Vázquez CL, Rodgers A, Herbst S, Coade S, Gronow A, Guzman CA, Wilson MS, Kanzaki M, Nykjaer A, Gutierrez MG.

Sci Rep. 2016 Jul 8;6:29332. doi: 10.1038/srep29332.

12.

Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.

Moise N, Huang C, Rodgers A, Kohli-Lynch CN, Tzong KY, Coxson PG, Bibbins-Domingo K, Goldman L, Moran AE.

Hypertension. 2016 Jul;68(1):88-96. doi: 10.1161/HYPERTENSIONAHA.115.06814. Epub 2016 May 15.

13.

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.

Xu Y, Hackett M, Carter G, Loo C, Gálvez V, Glozier N, Glue P, Lapidus K, McGirr A, Somogyi AA, Mitchell PB, Rodgers A.

Int J Neuropsychopharmacol. 2016 Apr 20;19(4). pii: pyv124. doi: 10.1093/ijnp/pyv124. Print 2016 Apr. Review.

14.

Transgenerational epigenetic programming via sperm microRNA recapitulates effects of paternal stress.

Rodgers AB, Morgan CP, Leu NA, Bale TL.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13699-704. doi: 10.1073/pnas.1508347112. Epub 2015 Oct 19.

15.

Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease.

Wood F, Salam A, Singh K, Day S, Jan S, Prabhakaran D, Rodgers A, Patel A, Thom S, Ward H.

BMJ Open. 2015 Sep 30;5(9):e008018. doi: 10.1136/bmjopen-2015-008018.

16.

Point Mutations in Centromeric Histone Induce Post-zygotic Incompatibility and Uniparental Inheritance.

Kuppu S, Tan EH, Nguyen H, Rodgers A, Comai L, Chan SW, Britt AB.

PLoS Genet. 2015 Sep 9;11(9):e1005494. doi: 10.1371/journal.pgen.1005494. eCollection 2015 Sep.

17.

Longitudinal patient-oriented outcomes in neuropathy: Importance of early detection and falls.

Callaghan B, Kerber K, Langa KM, Banerjee M, Rodgers A, McCammon R, Burke J, Feldman E.

Neurology. 2015 Jul 7;85(1):71-9. doi: 10.1212/WNL.0000000000001714. Epub 2015 May 27.

18.

Germ Cell Origins of Posttraumatic Stress Disorder Risk: The Transgenerational Impact of Parental Stress Experience.

Rodgers AB, Bale TL.

Biol Psychiatry. 2015 Sep 1;78(5):307-14. doi: 10.1016/j.biopsych.2015.03.018. Epub 2015 Mar 23. Review.

19.
20.

Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.

Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Yeni P, Strohmaier KM, Rodgers AJ, Barnard RJ, Nguyen BY, Teppler H; BENCHMRK Study Teams.

Antivir Ther. 2015;20(3):307-15. doi: 10.3851/IMP2912. Epub 2014 Oct 27.

Supplemental Content

Loading ...
Support Center